← Open Payments lookup

CARYN SCOTT: Open Payments

NPI 1023091618 · EUGENE, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$395 in 20 payments from 13 companies in 2025. Trend: 2023 $124 · 2024 $233 · 2025 $395

Food & beverage: $379Education: $16
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP3$57
GlaxoSmithKline, LLC.2$48
Amgen Inc.2$41
PFIZER INC.2$41
Exact Sciences Corporation2$40
ABBVIE INC.2$33
Sumitomo Pharma America, Inc.1$24
Axsome Therapeutics, Inc.1$23
Boehringer Ingelheim Pharmaceuticals, Inc.1$22
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$17

Products named: SHINGRIX, AIRSUPRA, VRAYLAR, OTEZLA, GEMTESA, Auvelity, PAXLOVID, JARDIANCE.

Industry payments across OR — which companies pay providers there.